Conmed (CNMD) Net Cash Flow (2010 - 2026)

Conmed's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$5.0 million for Q1 2026.

• Quarterly Net Cash Flow fell 148.72% year-over-year to -$5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 141.97% YoY) and the FY2025 annual result came in at $13.9 million, up 382.42% from the prior year.
• Net Cash Flow was -$5.0 million for Q1 2026 at Conmed, down from $1.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $29.6 million in Q2 2022 and bottomed at -$18.5 million in Q3 2022.
• A 5-year average of $914352.9 and a median of $1.4 million in 2023 frame the typical range for Net Cash Flow.
• Peak annual rise in Net Cash Flow reached 466.12% in 2024, while the deepest fall reached 421.96% in 2024.
• Conmed's Net Cash Flow stood at -$6.4 million in 2022, then retreated by 12.89% to -$7.2 million in 2023, then plunged by 62.91% to -$11.8 million in 2024, then soared by 115.75% to $1.9 million in 2025, then plunged by 368.23% to -$5.0 million in 2026.
• Business Quant data shows CNMD's Net Cash Flow at -$5.0 million in Q1 2026, $1.9 million in Q4 2025, and $5.0 million in Q3 2025.